Exclusive agreement with Biolab for Dapaconazole

We proudly announce that Triquim has been chosen by Biolab to be its strategic partner in the manufacture of Dapaconazole

BIOLAB SANUS PHARMACEUTICAL, one of the five largest Brazilian Laboratories developed and patented internationally its DAPACONAZOLE molecule.

For the exclusive manufacture of this innovative molecule, BIOLAB SANUS PHARMACEUTICAL has chosen TRIQUIM S.A, the latest generation Farmochemical plant with national and international certifications, serving the global market.

The exclusive agreement between the parties was signed last week, in the city of Sao Paulo, Brazil, strengthening the relationship between the parties for more than 4 decades.


We are thankful for the trust that Biolab places in Triquim